InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,048.42
(
-0.46%
)
US TECH 100
17,162.80
(
0.60%
)
Dow Jones
38,085.80
(
-0.98%
)
Brent Oil
88.29
(
0.15%
)
Bitcoin
64,551.55
(
0.10%
)
Post# of 197513
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

TPX

Send PM Follow Ignore
Followers 0
Posts 40567
Boards Moderated 4
Alias Born 10/24/2013

TPX

Re: None

Thursday, 02/09/2017 10:44:31 AM

Thursday, February 09, 2017 10:44:31 AM

Post# of 197513
$MCET MultiCell Immunotherapeutics: This information is current as of February 7, 2017.

Immunologic Control of Tumors by In Vivo Fc Receptor-Targeted Antigen Loading in Conjunction with Double-Stranded RNA-Mediated Immune Modulation

Alliance Pharmaceuticals and MultiCell Immunotherapeutics, San Diego, CA
92121; Mount Sinai School of Medicine, New York, NY 11029; and University of Missouri, Columbia, MO 65212

Complete article here! http://www.jimmunol.org/content/jimmunol/176/3/1363.full.pdf

>>> Trip Advisor IS A GROWING STOCK PICK BOARD NOW <<<

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up